Results about: cancer; RAS; Drosophila melanogaster

Researchers at IRB Barcelona manage to selectively eliminate cells that express the oncogene RAS, which is present in 30% of human cancers

In a study published in Cell Reports,the scientists inhibited the capacity of RAS to block cell death, thus eliminating malignant tumours without affecting the development of organs.

The results of the study pave the way to combining irradiation treatments with the administration of RAS pathway inhibitors to eliminate tumour cells.